Cargando…

Outcome of triple-negative breast cancer in patients with or without markers regulating cell cycle and cell death

PURPOSE: The genes p53 and B-cell lymphoma (bcl)-2 play an important role in regulating the mechanisms of apoptosis. In this paper, we retrospectively applied these factors to our series of triple negative breast cancer (TNBC) patients, in conjunction with an evaluation of the prognostic significanc...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ryu, Dong Won, Lee, Chung Han
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Korean Surgical Society 2012
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3467384/ https://www.ncbi.nlm.nih.gov/pubmed/23091790 http://dx.doi.org/10.4174/jkss.2012.83.4.187

Ejemplares similares

Clinical significance of morphologic characteristics in triple negative breast cancer
por: Ryu, Dong Won, et al.
Publicado: (2011)

Death effector domain-containing protein induces vulnerability to cell cycle inhibition in triple-negative breast cancer
por: Ni, Yingjia, et al.
Publicado: (2019)

Programmed cell death protein 1 is a marker for neoadjuvant chemotherapy response in triple-negative breast cancer
por: Gaui, Maria de Fátima Dias, et al.
Publicado: (2023)

Triple negative breast cancer: the kiss of death
por: Jitariu, Adriana-Andreea, et al.
Publicado: (2017)

Targeting Cell Death Mechanism Specifically in Triple Negative Breast Cancer Cell Lines
por: Pruteanu, Lavinia-Lorena, et al.
Publicado: (2022)

CIB1 depletion with docetaxel or TRAIL enhances triple-negative breast cancer cell death
por: Chung, Alexander H., et al.
Publicado: (2019)

Loss of PICH promotes chromosome instability and cell death in triple-negative breast cancer
por: Huang, Yan, et al.
Publicado: (2019)

Rosmarinic acid-induced apoptosis and cell cycle arrest in triple-negative breast cancer cells
por: Messeha, Samia S., et al.
Publicado: (2020)

Prognostic Value of Cancer Stem Cells Markers in Triple-Negative Breast Cancer
por: Collina, Francesca, et al.
Publicado: (2015)

Regulation of cancer stem cells in triple negative breast cancer
por: Fultang, Norman, et al.
Publicado: (2021)

Molecular Targets and Promising Therapeutics of Triple-Negative Breast Cancer
por: Ryu, Won-Ji, et al.
Publicado: (2021)

Supervised Machine Learning Predictive Analytics For Triple-Negative Breast Cancer Death Outcomes
por: Xu, Yucan, et al.
Publicado: (2019)

The miRNA-449 family mediates doxorubicin resistance in triple-negative breast cancer by regulating cell cycle factors
por: Tormo, Eduardo, et al.
Publicado: (2019)

Induced Cell Cycle Arrest in Triple-Negative Breast Cancer by Combined Treatment of Itraconazole and Rapamycin
por: Wu, Hua-Tao, et al.
Publicado: (2022)

Mouse mammary stem cells express prognostic markers for triple-negative breast cancer
por: Soady, Kelly J, et al.
Publicado: (2015)

Construction and Identification of New Molecular Markers of Triple-Negative Breast Cancer Stem Cells
por: Liu, Tingting, et al.
Publicado: (2021)

Opening large-conductance potassium channels selectively induced cell death of triple-negative breast cancer
por: Sizemore, Gina, et al.
Publicado: (2020)

Omega-3 docosahexaenoic acid induces pyroptosis cell death in triple-negative breast cancer cells
por: Pizato, Nathalia, et al.
Publicado: (2018)

Molecular characterization of circulating tumour cells identifies predictive markers for outcome in primary, triple‐negative breast cancer patients
por: Bittner, Ann‐Kathrin, et al.
Publicado: (2020)

Programmed cell death-ligand 1 expression in stromal immune cells is a marker of breast cancer outcome
por: Hong, Mineui, et al.
Publicado: (2020)

BCL2A1 regulates Canady Helios Cold Plasma-induced cell death in triple-negative breast cancer
por: Murthy, Saravana R. K., et al.
Publicado: (2022)

Association of Galectin 9 Expression with Immune Cell Infiltration, Programmed Cell Death Ligand-1 Expression, and Patient’s Clinical Outcome in Triple-Negative Breast Cancer
por: Ju, Mi-Ha, et al.
Publicado: (2021)

Isobavachalcone Induces Multiple Cell Death in Human Triple-Negative Breast Cancer MDA-MB-231 Cells
por: Wu, Cheng-Zhu, et al.
Publicado: (2022)

Triptolide Decreases Cell Proliferation and Induces Cell Death in Triple Negative MDA-MB-231 Breast Cancer Cells
por: Varghese, Elizabeth, et al.
Publicado: (2018)

ZNF703 promotes triple-negative breast cancer cells through cell-cycle signaling and associated with poor prognosis
por: Zhang, Xi, et al.
Publicado: (2022)

Thymoquinone Alterations of the Apoptotic Gene Expressions and Cell Cycle Arrest in Genetically Distinct Triple-Negative Breast Cancer Cells
por: Adinew, Getinet M., et al.
Publicado: (2022)

The clinicopathologic characteristics and prognostic significance of triple-negativity in node-negative breast cancer
por: Rhee, Jiyoung, et al.
Publicado: (2008)

IRES inhibition induces terminal differentiation and synchronized death in triple-negative breast cancer and glioblastoma cells
por: Vaklavas, Christos, et al.
Publicado: (2016)

Apoptotic Resistance of Metastatic Tumor Cells in Triple Negative Breast Cancer: Roles of Death Receptor-5
por: Kamalabadi-Farahani, Mohammad, et al.
Publicado: (2019)

Outcomes of Immediate Breast Reconstruction in Triple Negative Breast Cancer
por: Grigor, Emma, et al.
Publicado: (2021)

Proteogenomic Markers of Chemotherapy Resistance and Response in Triple-Negative Breast Cancer
por: Anurag, Meenakshi, et al.
Publicado: (2022)

Clinical features and their effect on outcomes of patients with triple negative breast cancer with or without lymph node involvement
por: Sobočan, Monika, et al.
Publicado: (2019)

Differential cytotoxic and radiosensitizing effects of silver nanoparticles on triple-negative breast cancer and non-triple-negative breast cells
por: Swanner, Jessica, et al.
Publicado: (2015)

Current situation of programmed cell death protein 1/programmed cell death ligand 1 inhibitors in advanced triple-negative breast cancer
por: Liang, Yuehua, et al.
Publicado: (2022)

In vivo validation of metastasis-regulating microRNA-766 in human triple-negative breast cancer cells
por: Oh, Keunhee, et al.
Publicado: (2017)

The phosphatase PPM1A inhibits triple negative breast cancer growth by blocking cell cycle progression
por: Mazumdar, Abhijit, et al.
Publicado: (2019)

WEE1 inhibition targets cell cycle checkpoints for triple negative breast cancers to overcome cisplatin resistance
por: Zheng, Hongping, et al.
Publicado: (2017)

Author Correction: Omega-3 docosahexaenoic acid induces pyroptosis cell death in triple-negative breast cancer cells
por: Pizato, Nathalia, et al.
Publicado: (2018)

Mevastatin blockade of autolysosome maturation stimulates LBH589-induced cell death in triple-negative breast cancer cells
por: Lin, Zhaohu, et al.
Publicado: (2017)

A Novel Thienopyrimidine Analog, TPH104, Mediates Immunogenic Cell Death in Triple-Negative Breast Cancer Cells
por: Tukaramrao, Diwakar Bastihalli, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_1e2rgb7572o0tn2srh6rlhd4jb